Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes

With breast cancer ranking first among the most common malignant neoplasms in the world, new techniques of early detection are in even more demand than before. Our awareness of tumors’ biology is expanding and may be used to treat patients more efficiently. A link between radiology and pathology was...

Descripción completa

Detalles Bibliográficos
Autores principales: Luczynska, Elzbieta, Piegza, Tomasz, Szpor, Joanna, Heinze, Sylwia, Popiela, Tadeusz, Kargol, Jaromir, Rudnicki, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598186/
https://www.ncbi.nlm.nih.gov/pubmed/36289645
http://dx.doi.org/10.3390/biomedicines10102384
_version_ 1784816269874167808
author Luczynska, Elzbieta
Piegza, Tomasz
Szpor, Joanna
Heinze, Sylwia
Popiela, Tadeusz
Kargol, Jaromir
Rudnicki, Wojciech
author_facet Luczynska, Elzbieta
Piegza, Tomasz
Szpor, Joanna
Heinze, Sylwia
Popiela, Tadeusz
Kargol, Jaromir
Rudnicki, Wojciech
author_sort Luczynska, Elzbieta
collection PubMed
description With breast cancer ranking first among the most common malignant neoplasms in the world, new techniques of early detection are in even more demand than before. Our awareness of tumors’ biology is expanding and may be used to treat patients more efficiently. A link between radiology and pathology was searched for in our study, as well as the answer to the question of whether a tumor type can be seen on contrast-enhanced mammography and if such knowledge may serve as part of precision medicine.
format Online
Article
Text
id pubmed-9598186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95981862022-10-27 Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes Luczynska, Elzbieta Piegza, Tomasz Szpor, Joanna Heinze, Sylwia Popiela, Tadeusz Kargol, Jaromir Rudnicki, Wojciech Biomedicines Article With breast cancer ranking first among the most common malignant neoplasms in the world, new techniques of early detection are in even more demand than before. Our awareness of tumors’ biology is expanding and may be used to treat patients more efficiently. A link between radiology and pathology was searched for in our study, as well as the answer to the question of whether a tumor type can be seen on contrast-enhanced mammography and if such knowledge may serve as part of precision medicine. MDPI 2022-09-24 /pmc/articles/PMC9598186/ /pubmed/36289645 http://dx.doi.org/10.3390/biomedicines10102384 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Luczynska, Elzbieta
Piegza, Tomasz
Szpor, Joanna
Heinze, Sylwia
Popiela, Tadeusz
Kargol, Jaromir
Rudnicki, Wojciech
Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
title Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
title_full Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
title_fullStr Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
title_full_unstemmed Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
title_short Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes
title_sort contrast-enhanced mammography (cem) capability to distinguish molecular breast cancer subtypes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598186/
https://www.ncbi.nlm.nih.gov/pubmed/36289645
http://dx.doi.org/10.3390/biomedicines10102384
work_keys_str_mv AT luczynskaelzbieta contrastenhancedmammographycemcapabilitytodistinguishmolecularbreastcancersubtypes
AT piegzatomasz contrastenhancedmammographycemcapabilitytodistinguishmolecularbreastcancersubtypes
AT szporjoanna contrastenhancedmammographycemcapabilitytodistinguishmolecularbreastcancersubtypes
AT heinzesylwia contrastenhancedmammographycemcapabilitytodistinguishmolecularbreastcancersubtypes
AT popielatadeusz contrastenhancedmammographycemcapabilitytodistinguishmolecularbreastcancersubtypes
AT kargoljaromir contrastenhancedmammographycemcapabilitytodistinguishmolecularbreastcancersubtypes
AT rudnickiwojciech contrastenhancedmammographycemcapabilitytodistinguishmolecularbreastcancersubtypes

Ejemplares similares